LAS VEGAS, NV--(Marketwire - Oct 22, 2012) - Given Imaging Ltd (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced data from numerous studies ...

YOQNEAM, ISRAEL--(Marketwire - Jan 3, 2013) - Given Imaging Ltd (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced the launch of ManoView™ ESO v3.0, ...

AMSTERDAM, THE NETHERLANDS--(Marketwire - Oct 21, 2012) - Given Imaging Ltd (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced new studies ...

Given Imaging Ltd. (NASDAQ: GIVN) today announced two new studies underscoring the value of Bravo® pH Monitoring in patients with gastroesophageal reflux disease (GERD). The studies re-affirm the ...

Given Imaging announced numerous studies confirming the value of its reflux and manometry products in diagnosing, monitoring and managing a range of gastrointestinal diseases. The studies were ...

The anorectal manometry systems market in North America is projected to have large share over the forecast period followed by Western Europe owing to the increasing elderly population and favorable ...

Advances Covidien strategy to more comprehensively address key specialties and procedures globally Adds Given Imaging’s broad suite of minimally invasive gastrointestinal diagnostic and monitoring ...